Acceptance and benefit of pruritus measurement in dermatological routine care

Recruiting

• Conditions: L29.8; L50.8; L40.0; L20.9; L28.1; Other pruritus; Other urticaria; Psoriasis vulgaris; Atopic dermatitis, unspecified; Prurigo nodularis

• Registration Number: DRKS00015305
• Lead Sponsor: Westfälische Wilhelms-Universität Münster

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-02-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Patients
-older than 18 years old
-chronic pruritus (for more than 6 weeks)
-intensity of pruritus higher than NRS 3 (24h)
-one of the following four diagnoses: atopic dermatitis (L20.9), prurigo nodularis (L28.1), psoriasis vulgaris (L40.0) or chronic urticaria (L50.8).

Exclusion Criteria

-lack of understanding of the German language;
-Patients who are not able to consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
-intensity of pruritus: Numeric Rating Scale NRS, Itch Controlled Days Questionnaire<br><br>-quality of life: Dermatologic Life Quality Index DLQI, 5-PLQ<br><br>-benefit to the Patient: Likert Scales<br><br>-benefit to the physician: Likert Scales<br><br>Measurement once per study visit

Secondary Outcome Measures

Name	Time	Method
-clinical improvement during study horizon of 6-12 months<br>